Open AccessAcupoint injection versus sacral canal injection in lumbar disc herniation
Author(s) -
Wei Li,
Huaying Wang,
Lijun Wang,
Peng Tang,
Yaokai Huang
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023000
Subject(s) - medicine , oswestry disability index , randomized controlled trial , lumbar disc herniation , visual analogue scale , lumbar , surgery , adverse effect , clinical trial , lumbar vertebrae , low back pain , alternative medicine , pathology
Background: Both acupoint injection and sacral canal injection are widely adopted in the treatment of lumbar disc herniation (LDH), but there are still doubts about the effectiveness and safety of the 2 methods. Therefore, the objective of the randomized controlled trial is to evaluate the effectiveness and safety of acupoint injection and sacral canal injection in the treatment of LDH. Method: This is a prospective randomized controlled trial to study the effectiveness and safety of acupoint injection and sacral canal injection in the treatment of LDH. With the approval by the clinical research ethics committee of our hospital, patients were randomly included into 1 of 2 treatment protocols: (1) acupoint injection group and (2) sacral canal injection group. Patients, doctors, nurses, and research assistants responsible for collecting data were blinded to group allocation. Main outcome observation indicator: visual analogue scale; secondary outcome observation indicator: Oswestry disability index scores; paresthesia score; adverse reactions. Data were analyzed using the statistical software package SPSS version 25.0 (Chicago, IL). Discussion: The effectiveness and safety of acupoint injection and sacral canal injection in the treatment of LDH were evaluated in this study, and the results of this trial would establish clinical evidence for the adoption of acupoint injection or sacral canal injection to treat LDH. Trial registration number: DOI 10.17605 / OSF.IO / VTFUD